Genexine-KGbio's CKD-linked anaemia drug gains approval
The Indonesian Ministry of Food and Drug Safety approved Genexine and KGbio's Efepoetin alfa for chronic kidney disease-induced anaemia.
Source: pharmaceutical-technology.com
Roche Mircera News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roche Mircera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roche Mircera Today - Breaking & Trending Today
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--
Source: eagletribune.com
Genexine's Long-acting Anemia Treatment GX-E4 Phase 3 Clinical Trial Interim Result Is Presented at WCN2023, Confirmed Non-inferiority Compared to Mircera
SEOUL, South Korea--(BUSINESS WIRE)--A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase 3 clinical trial of GX-E4 (Efepoetin alfa), a candidate for CKD (Chronic Kidney Disease) induced ane...
Source: pharmiweb.com
Renal Anemia Market Revs Up in Europe With the Launch of FibroGen Inc's/Astellas Pharma's EVRENZO (Roxadustat), Spherix Global Insights Reports
/PRNewswire/ -- For decades, nephrologists across the globe have prescribed erythropoietin stimulating agents (ESAs), such as Amgen's Aranesp, Roche's Mircera,...
Source: prnewswire.com
Renal Anemia Market Revs Up in Europe With the Launch of FibroGen Inc's/Astellas Pharma's EVRENZO (Roxadustat), Spherix Global Insights Reports
/PRNewswire/ -- For decades, nephrologists across the globe have prescribed erythropoietin stimulating agents (ESAs), such as Amgen's Aranesp, Roche's Mircera,...
Source: prnewswire.com